A Pik3caH1047R mutation targeted to mouse mammary cells demonstrates that this constitutively activated mutant PI3K p110α catalytic subunit, also seen in many human cancers, drives tumor heterogeneity and the emergence of secondary oncogenic mutations [13]. The gene discussed is PIK3CA; the disease is neoplasm.